Welcome and rationale for androgen society


The Androgen Society is the first international society dedicated entirely to the study of hypogonadism and its treatment. Founded in 2017, the Androgen Society is an international medical and scientific society dedicated to the study of hypogonadism, also called testosterone deficiency, and its treatment.

The mission of the Androgen Society is to promote excellence in research, education and clinical practice, bringing together experts and interested individuals from all disciplines within medicine, including endocrinology, urology, general medicine, sexual medicine, and epidemiology, among others. Activities of the Androgen Society include annual meetings, newsletters, website and additional educational events as they may occur. The Androgen Society believes the important field of testosterone research will benefit from bringing together various medical disciplines, who customarily operate in isolation.

The Androgen Society originated from an international expert consensus conference about testosterone deficiency and its treatment held 2015 in Prague.1 There were 18 experts from 11 countries on 4 continents. Specialties included urology, endocrinology, internal medicine, diabetology, and basic science research. Experts were invited on the basis of extensive clinical experience with testosterone deficiency and its treatment and/or research experience.

The impetus for this expert consensus conference was to address the widespread misinformation and confusion about testosterone deficiency and testosterone therapy.2 The ultimate goal of this consensus conference was to document what is true or untrue about testosterone deficiency and testosterone therapy, to the best degree possible based on existing scientific and clinical evidence. The outcome was summarized in nine resolutions:

  • Testosterone deficiency is a well-established, significant medical condition that negatively affects male sexuality, reproduction, general health, and quality of life.
  • Symptoms and signs of testosterone deficiency occur as a result of low levels of testosterone and may benefit from treatment regardless of whether there is an identified underlying cause.
  • Symptoms and signs of testosterone deficiency should get more attention because of the limitations of measuring and interpreting testosterone levels in men.
  • Testosterone deficiency is a global public health concern.
  • Testosterone therapy for men with testosterone deficiency is effective, rational, and evidence based.
  • There is no scientific basis for any age-specific recommendations against the use of testosterone therapy in men.
  • The evidence does not support increased risk of cardiovascular events with testosterone therapy.
  • The evidence does not support increased risk of prostate cancer with testosterone therapy.
  • Evidence supports a major research initiative to explore possible benefits of testosterone therapy for cardiometabolic disease, including diabetes.

Hypogonadism is associated with significant adverse health outcomes and increased mortality. Clinical experience and high-level evidence indicates that testosterone therapy has substantial benefits for men with low testosterone.



Prof. Dr. med. Marija Pfeifer

Abraham Morgentaler, MD
President, the Androgen Society
Associate Clinical Professor of Urology, Harvard Medical School, Boston, Massachusetts


  • Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. Mayo Clin. Proc. 2016;91(7):881-896. Return to content
  • Morgentaler A, Zitzmann M, Traish AM, Fox A. International expert consensus conference on testosterone deficiency and its treatment held in Prague, Czech Republic. The aging male : the official journal of the International Society for the Study of the Aging Male. 2015;18(4):205-206. Return to content